Louisiana State Employees Retirement System increased its stake in shares of Natus Medical Incorporated (NASDAQ:BABY) by 0.7% during the second quarter, Holdings Channel reports. The fund owned 13,500 shares of the medical equipment provider’s stock after buying an additional 100 shares during the period. Louisiana State Employees Retirement System’s holdings in Natus Medical were worth $504,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Karp Capital Management Corp bought a new position in Natus Medical during the first quarter valued at $242,000. Intrust Bank NA boosted its position in Natus Medical by 3.7% in the first quarter. Intrust Bank NA now owns 8,229 shares of the medical equipment provider’s stock valued at $323,000 after buying an additional 295 shares during the last quarter. Comerica Bank boosted its position in shares of Natus Medical by 3.6% in the first quarter. Comerica Bank now owns 36,642 shares of the medical equipment provider’s stock worth $1,299,000 after buying an additional 1,289 shares during the last quarter. Algert Global LLC acquired a new position in shares of Natus Medical during the first quarter worth approximately $479,000. Finally, Great West Life Assurance Co. Can boosted its position in shares of Natus Medical by 8.1% in the first quarter. Great West Life Assurance Co. Can now owns 46,857 shares of the medical equipment provider’s stock worth $1,837,000 after buying an additional 3,512 shares during the last quarter. 93.86% of the stock is owned by institutional investors.

Shares of Natus Medical Incorporated (NASDAQ BABY) traded up 0.76% during trading on Friday, hitting $33.35. 113,244 shares of the company’s stock were exchanged. The company has a 50-day moving average of $36.51 and a 200-day moving average of $36.73. The company has a market cap of $1.08 billion, a P/E ratio of 57.80 and a beta of 0.93. Natus Medical Incorporated has a 12-month low of $32.83 and a 12-month high of $44.39.

Natus Medical (NASDAQ:BABY) last announced its earnings results on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.33 by $0.01. The company had revenue of $122.20 million during the quarter, compared to analyst estimates of $121.99 million. Natus Medical had a net margin of 4.20% and a return on equity of 12.09%. Natus Medical’s revenue was up 27.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.39 earnings per share. On average, equities analysts expect that Natus Medical Incorporated will post $1.70 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Natus Medical Incorporated (NASDAQ:BABY) Shares Bought by Louisiana State Employees Retirement System” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/natus-medical-incorporated-nasdaqbaby-shares-bought-by-louisiana-state-employees-retirement-system/1475986.html.

A number of equities analysts have commented on the stock. BidaskClub cut shares of Natus Medical from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research cut shares of Natus Medical from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. TheStreet cut shares of Natus Medical from a “b” rating to a “c+” rating in a research note on Thursday, April 27th. Finally, Benchmark Co. reissued a “buy” rating and issued a $48.00 price objective (down from $55.00) on shares of Natus Medical in a research note on Monday, May 1st. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. Natus Medical presently has an average rating of “Hold” and a consensus price target of $45.00.

In related news, insider James B. Hawkins bought 4,000 shares of the stock in a transaction on Thursday, June 15th. The stock was bought at an average price of $33.98 per share, with a total value of $135,920.00. Following the completion of the purchase, the insider now directly owns 578,023 shares in the company, valued at approximately $19,641,221.54. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Doris Engibous sold 5,000 shares of the stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $32.68, for a total transaction of $163,400.00. Following the transaction, the director now directly owns 22,650 shares of the company’s stock, valued at approximately $740,202. The disclosure for this sale can be found here. Company insiders own 5.50% of the company’s stock.

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Incorporated (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.